Breaking news

Meghalaya Governor Satya Pal Malik’s stand has not softened even after moreAll You Need to Know About Cryptocurrency in India: Trends, Legality and more The Champaran Foundation, in collaboration with InFeed, organised an online more In one of the biggest leaks ever of offshore financial records, the more The Champaran Foundation, in collaboration with InFeed, is inviting entries more The recently concluded German elections on September 26, 2021 have given a more According to latest news reports, China has been on a defense infrastructure more A new line of argument has already come to dominate the public sphere: it’ more The government has gone one step further to detect community spread of the more The government has issued an order to abolish the six allowances, including more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected more SEOUL| South Korea’s unemployment rate was unchanged in April as the more Amid the outbreak of Corona pandemic in the country, Indian government has more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated more Corona infection in the country is taking a macabre form. So far, more than 74 more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh more

Russia Approves Second Corona Vaccine After Initial Trials

Corona Vaccine

The practice of making Corona vaccine is going on all over the world. Meanwhile, there is good news that Russia has claimed to have made another vaccine of the corona virus. Russia has approved its second corona vaccine after the initial trial. During a meeting with government officials, Russian President Vladimir Putin announced on Wednesday that the country has approved the second corona virus vaccine ‘EpiVacCorona’ after the initial trial. Let me tell you that before this, Russia has created Sputnik-5 vaccine of Corona.

Russian President Vladimir Putin said that now we need to increase the production of the first and second vaccine. This vaccine has been produced by the Vectors Institute in Siberia, which is peptide-based and requires two doses of this vaccine to protect against corona. It has been tested on around 100 volunteers.

According to news agency PTI, it has been tried for two months and now approved after the completion of its initial study two weeks ago. It is being told that the initial trials of this vaccine have been successful and that the volunteers who participated in this trial were aged between 18 and 60 years.

However, scientists have not yet published the results of the study. Scientists who developed the vaccine in an interaction with the media said that it produces enough antibodies to protect the person from the corona virus and the immunity it creates can last up to six months.

Russia’s Deputy Prime Minister Tatyana Golikova has received this vaccine. He had earlier said that he also participated in the initial trial as a volunteer. Golikova has said that 40,000 volunteers across the country will be selected for the next phase trial of Corona’s ‘EpiVacCorona’ vaccine. However, it is unclear whether the vaccine will be offered for wider use while trials are still ongoing. Let us know that earlier on 11 August Russia approved the world’s first corona virus vaccine Sputnik V.

Story Page